Edge Advisors’s Abiomed Inc ABMD Stock Holding History

Edge Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$106K	Hold	260	–	–	0.01%	392
2018 Q1	$75K	Buy	260 +85	+49%	+$21.5K	0.01%	467
2017 Q4	$32K	Hold	175	–	–	﹤0.01%	596
2017 Q3	$29K	Buy	+175	New	+$26.5K	﹤0.01%	602

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edge Advisors's ABMD Position: Q2 2018 in Review

Edge Advisors held its Abiomed Inc (ABMD) position steady in Q2 2018 at 260 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #392.

Edge Advisors first reported a position in ABMD in Q3 2017 and has held it in 4 quarters since. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

Edge Advisors held 260 shares of Abiomed Inc worth $106K as of Q2 2018.
Edge Advisors left its Abiomed Inc share count unchanged in Q2 2018.
Abiomed Inc made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #392 holding.
Edge Advisors first reported a position in Abiomed Inc in Q3 2017 and has held it in 4 quarters since.
527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.